A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients (SuppCare 001)
Clinical trial NCT05284032 · TERMINATED
Trial details
- NCT number
- NCT05284032
- Sponsor
- Firas El Chaer, MD
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-29
- Primary completion
- 2024-06-11
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.